Jump to content

Methylenedioxymethoxyethylamphetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 12:39, 10 February 2016 (Updating {{chembox}} (changes to verified and watched fields - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'Verifiedfields', 'Watchedfields') per Chem/Drugbox validation (report [[Wikipedia_talk:WikiProject_Chemicals...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Methylenedioxymethoxyethylamphetamine
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 ☒N
    Key: LOZJEWOZOKSOKA-UHFFFAOYSA-N ☒N
  • InChI=1/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3
    Key: LOZJEWOZOKSOKA-UHFFFAOYAB
  • CC(Cc1ccc2c(c1)OCO2)NCCOC
Properties
C13H19NO3
Molar mass 237.295 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

MDMEOET, or 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.

See also

Template:PiHKAL